




Searching News Database: Revance Therapeutics
HSMN NewsFeed - 25 Mar 2013
Revance Therapeutics Announces Appointment of Lauren Silvernail as Chief Financial Officer
Revance Therapeutics Announces Appointment of Lauren Silvernail as Chief Financial Officer
HSMN NewsFeed - 8 May 2008
Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
HSMN NewsFeed - 27 Dec 2007
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
Additional items found! 2

Members Archive contains
2 additional stories matching:
Revance Therapeutics
(Password required)
Revance Therapeutics
(Password required)